Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Aug 20;16(8):e0255578. doi: 10.1371/journal.pone.0255578

Physician perceived barriers and facilitators for self-measured blood pressure monitoring- a qualitative study

Saahith Gondi 1, Shellie Ellis 2, Mallika Gupta 3, Edward Ellerbeck 2, Kimber Richter 2, Jeffrey Burns 4, Aditi Gupta 3,4,*
Editor: Vijayaprakash Suppiah5
PMCID: PMC8378703  PMID: 34415946

Abstract

Introduction

Improving hypertension management is a national priority that can decrease morbidity and mortality. Evidence-based hypertension management guidelines advocate self-measured BP (SMBP), but widespread implementation of SMBP is lacking. The purpose of this study was to describe the perspective of primary care physicians (PCPs) on SMBP to identify the barriers and facilitators for implementing SMBP.

Methods

We collected data from PCPs from a large health system using semi-structured interviews based on the Theoretical Domains Framework (TDF). Responses were recorded, transcribed, and qualitatively analyzed into three overarching TDF domains based on the Behavior Change Wheel (BCW): 1) Motivation 2) Opportunity and 3) Capabilities. The sample size was based on theme saturation.

Results

All 17 participating PCPs believed that SMBP is a useful, but underutilized tool. Although individual practices varied, most physicians felt that the increased data points from SMBP allowed for better hypertension management. Most felt that overcoming existing barriers would be difficult, but identified several facilitators: physician support of SMBP, the possibility of having other trained health professionals to assist with SMBP and patient education; improving patient engagement and empowerment with SMBP, and the interest of the health system in using technology to improve hypertension management.

Conclusion

PCPs believe that SMBP can improve hypertension management. There are numerous barriers and facilitators for implementing SMBP. Successful implementation in clinical practice will require implementation strategies targeted at increasing patient acceptability and reducing physician workload. This may need a radical change in the current methods of managing hypertension.

Introduction

Hypertension is a major modifiable risk factor for cardiovascular events, stroke, chronic kidney disease, dementia, hospitalizations, and mortality [16]. In the US only one in two hypertensive adults have adequately controlled blood pressure (BP) [7, 8]. This is a lost opportunity as intensive BP control, if fully implemented, is estimated to prevent ≈107,500 deaths per year [9]. With these data, improving BP control is a national priority and the Office of the Surgeon General is committed to improving hypertension management [10].

The need to treat hypertension was first realized in the late 1900’s [11] and a plethora of guidelines have evolved since. Despite evidence-based guidelines, increased physician awareness, and Medicare expenditures in excess of $50 billion/year, success in reducing BP has declined in recent years [12]. These data indicate an urgent need to reassess current strategies and implement new ones for improving hypertension management.

An important, but often overlooked barrier to effective hypertension management is the widely used practice of relying on in-clinic BP readings. Compared to in-clinic BP monitoring, out-of-office or self-measured blood pressure monitoring (SMBP), sometimes also called home blood pressure monitoring, especially when augmented with telemonitoring and/or counseling [13], is more effective in lowering BP [1316], cost effective [17, 18], preferred by patients, better at detecting white-coat hypertension and masked hypertension [19], and improves outcomes [20]. Some of these benefits are related to the ability to get an increased number of BP readings which enables better decision making by physicians [21]. National initiatives like the American Medical Association/ American Heart Association’s “TargetBP” [22], and the Centers for Disease Control and Prevention (CDC)/ Centers for Medicare and Medicaid Services’ (CMS’s) “Million Hearts” [23] have been working for years on widespread implementation of SMBP. However, despite being proven effective over 20 years ago [14, 15], being integrated into hypertension management guidelines [7, 24], and being the focus of these prominent national initiatives, SMBP has not been widely implemented in the real world; there remains a disconnect between the evidence-based guidelines and implementation of SMBP in clinical practice. Implementation science is an approach ideally suited to address this disconnect [25].

Implementation science is a theoretically based social science devoted to accelerating the uptake, optimal implementation, and sustained use of evidence-based medicine in clinical practice [25, 26]. By identifying underlying determinants related to adoption and implementation of an evidence-based practice, such as SMBP, implementation science methodology can guide the systematic mapping of evidence-based implementation strategies known to address the particular behavioral determinants faced. These determinants span user motivation, opportunity, and capability to use the evidence-based practice [27, 28] as well as the characteristics of the evidence-based practice itself such as its feasibility and compatibility with the practice environment [29].

Identifying barriers is important to develop successful strategies. Some patient [30, 31] and organization level barriers—cost of home BP cuffs and inability to measure BP accurately [19, 21, 32], poorly aligned incentives, and lack of decision support tools and feedback mechanisms [3335] have been identified. Since primary care physicians (PCPs) are integral to the management of hypertension, understanding their views on SMBP to manage hypertension is essential to develop and successfully implement strategies for SMBP. Although most physicians report use of SMBP in varying form and extent [36], few have policies and systems in place to ensure appropriate use of SMBP [37]. Engaging PCPs in problem solving around the barriers to SMBP not only improves the strategies but builds credibility of interventions for future dissemination.

To provide the needed context for developing strategies to implement SMBP for improved management of hypertension, we summarize the perspective of PCPs; characterize their knowledge, attitude, beliefs, capabilities, motivation, and practices related to hypertension management and SMBP to identify the barriers and facilitators for SMBP.

Methods

A preliminary survey regarding SMBP followed by a semi-structured interview was conducted among PCPs to understand the perceived barriers and facilitators for SMBP. This project was approved by the University of Kansas Medical Center Institutional Review Board as a Quality Improvement project. Need for consent was waived under the quality improvement determination. Participation in surveys and interviews was voluntary. No financial or other incentives were offered to the respondents. Respondents could refuse to answer any question at any time. The purpose of the survey and the interview was discussed and verbal permission to record the interview was obtained before each interview from all respondents. No additional information or data from clinical trials on SMBP was offered to the respondents.

Theoretical domains framework

We used the Theoretical Domains Framework (TDF) [28] as our conceptual model. The TDF consolidates 84 constructs of behavior change derived from psychological and social theories into a single framework to assess implementation problems and inform intervention design. The constructs were organized into 12 validated and two additional domains relevant to PCPs’ clinical behavior change [38]. We used the TDF to structure the interview guide, specific questions and probes, and to inform the data analysis and results presentation. We further organized these domains of the TDF within the three overarching categories of Motivation, Opportunity, and Capabilities based on the Behavior Change Wheel (BCW) (Fig 1) [27, 28]. An individual’s Motivation consists of processes that promote and energize the behavior. Physical and social Opportunity prompt and allow for the behavior to occur. Capabilities refer to an individual’s psychological and physical ability to engage in the behavior. The BCW organization of the different determinant domains facilitates understanding of the implications of behavioral changes [27, 28]. We chose the TDF among the popular determinant frameworks based on our substantial experience with the framework [3942], its comprehensiveness of a full range of potential determinants, its thorough exploration of individual motivation pertinent to individual healthcare providers’ prescribing decisions, and its utility in combination with the BCW in implementation strategy selection, with the latter two reasons distinguishing it from other popular frameworks.

Fig 1. TDF domains analyzed under behavior change wheel.

Fig 1

Participants

We interviewed family medicine and internal medicine PCPs from a large health system. The physicians were approached by the research team (AG) during departmental faculty meetings. The research team introduced the study and invited faculty members to take a brief survey about hypertension management and their use of SMBP with responses in 5-point Likert scale. The participants could access the survey on their phone through a QR code or use a paper form. The last question of the survey asked if they were willing to be contacted for a 30-45-minute interview. The survey was anonymous and only the physicians who agreed to be contacted for the interview were asked to reveal their identity and were later contacted for the interview. Additional interested PCPs were also invited to participate in the interview to achieve thematic saturation.

Setting

All respondents were from a single, large health system in the area providing over 920,000 annual outpatient visits and caring for patients from a large geographic area comprised of both urban and rural population. The health systems electronic health record is well developed and has a patient portal (MyChart) actively used by more than 80% of the patients. The patient portal also enables PCPs to obtain self-recorded SMBP readings from patients that can be reviewed by their PCP. The mean age of patients seen by primary care was 57±18 years (2019 pre- COVID-19 pandemic data) with approximately 60% of the patients being female. The racial/ethnic breakdown of patients was 71.8% White, 6% Hispanic, 2.5% Asian, 1.7% Black, and 18% unknown or other. Of the patients with hypertension, 75% were White and 18% Black. Approximately 49% of all patients with a BP reading had at least one systolic BP >130 mmHg. The respondents are expected to have a similar mix of patients as our health system, as most new patients are randomly assigned to available physicians.

Sample size

Sample adequacy was assessed by thematic saturation rather than effect size. Based on recommendations to reach saturation [4345], and our prior experience [46, 47], we anticipated a sample size of about 15 but also planned to increase the sample size if we did not reach saturation on important themes.

The interview guide

Two investigators (AG and SE) developed the semi-structured interview guide based on the TDF [48] and our previous qualitiative studies utilizing the approach [3942]. The interview guide (S1 File) explored each domain of the TDF through specific items or prompts and incorporated behaviors including general hypertension management, SMBP recommendation and management, and potential intervention strategies that might address known barriers to both. Questions were prioritized to ensure a broad range of determinants would be addressed within the participants’ time constraints. Consistent with qualitative research, the guide was not considered a verbatim questionnaire, but merely a prompt to ensure the participants considered a comprehensive set of determinants. Because initial survey results indicated some physicians were not enthusiastic about nurse-led SMBP, we specifically probed on the appropriateness of pharmacists’ potential role in SMBP. A final question asked the participants to prioritize the determinants discussed.

Interviewers and data collection

After identification of interested physicians, a research assistant (SG), a relative “naive” lay person (without previous knowledge of hypertension management or SMBP) conducted semi-structured interviews. The research assistant was trained on use of the interview guide and qualitative interviewing techniques by the qualitative methodologist on the team (SE). The principal investigator (AG), a nephrologist in the same institution with professional relationship with the respondents introduced the research assistant to all the respondents and observed him during the first two interviews. After the initial onboarding period, one-time interviews were conducted independently by the research assistant to optimize explanatory communication behaviors of the PCPs to the “naive” interviewer [49]. We specifically selected a non-physician team member as the interview facilitator to avoid leading or judgmental questions or influencing responses based on clinical knowledge and experience in hypertension management.

Interviews were initially conducted in a private room, usually the physician’s office. After March 2020, the remaining interviews were conducted via phone to maintain safety during the COVID-19 pandemic. Based on the physicians’ answers, the inclusion and order of the questions varied. The interviews were audio recorded and sent for transcription by a third party.

Data analysis

Each transcript was reviewed for mis-transcription and coded using a template analysis strategy by categorizing the individual responses according to the TDF domains. We used a TDF codebook developed a priori and used in our previous studies. TDF domain definitions, examples, and counter examples were used for reference to ensure accurate categorization. Interviews were coded by multiple analysts (SG, AG, SE) for training purposes until consensus on the application of TDF domains was reached and completed by a single coder (SG). Interview content assigned to each domain was further synthesized and sub-themes within each were identified. Since most responses fell under 10 domains, two domains; knowledge and nature of behavior; were not reported. The responses were then organized within the three major behavioral determinants based on the BCW [27, 28]. The behavioral differences and trends were noted and general inferences were drawn regarding the overall beliefs. Analytical inferences were drawn regarding the overall beliefs surrounding SMBP utilizing the three BCW intervention drivers. Further analysis regarding SMBP was assessed based on the collective responses and general themes categorized within the three BCW categories to better understand beliefs around future implementation of SMBP.

Results

Thirty-nine physicians completed the initial survey. Most physicians reported satisfaction with current BP control (Table 1A). A majority indicated that additional intervention such as nurses’ visits in between PCP visits, more frequent follow up, or use of out of clinic BP monitoring may be appropriate. Physicians were supportive of most of these alternative interventions, although some were less likely to support additional nursing visits. Most physicians recommended SMBP to some extent, but many did not use the patient portal to collect SMBP measurements.

Table 1. Results of the survey on hypertension management a) from the 39 primary care physicians initially approached and b) from 14 primary care physicians who completed the interview.

a)
Question Responses n (%)
Very satisfied Somewhat satisfied Neither satisfied nor unsatisfied Somewhat unsatisfied Very unsatisfied
How would you rate your satisfaction with the current BP control of your patients? 1 (3) 21 (54) 6 (15) 11(28) 0
Please rate the appropriateness of alternative strategies for improving hypertension management
Very appropriate Somewhat appropriate Neither appropriate nor inappropriate Somewhat inappropriate Very inappropriate
Nurse visits in between provider visits 27 (69) 8 (21) 1 (3) 1 (3) 2 (5)
More frequent follow up with provider 16 (41) 15 (39) 4 (10) 4 (10) 0
Ambulatory BP monitoring 21 (54) 13 (33) 1 (3) 3 (8) 1 (3)
Home/other out of office (e.g.: grocery store, pharmacy etc.) BP monitoring 10 (26) 21 (54) 5 (13) 2 (5) 1 (3)
Always recommend Often recommend Sometimes recommend Rarely recommend Never recommend
Do you recommend SMBP monitoring to your patients? 18 (46) 18 (46) 1 (3) 2 (5) 0
Always Often Sometimes Rarely Never
Do you use the MyChart SMBP monitoring tool? 4 (10) 11 (28) 7 (18) 6 (15) 11 (28)
b)
Question Responses n (%)
Very satisfied Somewhat satisfied Neither satisfied nor unsatisfied Somewhat unsatisfied Very unsatisfied
How would you rate your satisfaction with the current BP control of your patients? 1 (7) 7 (50) 3 (21) 3 (21) 0
Please rate the appropriateness of alternative strategies for improving hypertension management
Very appropriate Somewhat appropriate Neither appropriate nor inappropriate Somewhat inappropriate Very inappropriate
Nurse visits in between provider visits 10 (71) 3 (21) 0 1 (7) 0
More frequent follow up with provider 8 (57) 3 (21) 2 (14) 1 (7) 0
Ambulatory BP monitoring 9 (64) 4 (29) 1 (7) 0 0
Home/other out of office (e.g.: grocery store, pharmacy etc.) BP monitoring 3 (21) 9 (64) 2 (14) 0 0
Always recommend Often recommend Sometimes recommend Rarely recommend Never recommend
Do you recommend SMBP monitoring to your patients? 2 (14) 11 (79) 1 (7) 0 0
Always Often Sometimes Rarely Never
Do you use the MyChart SMBP monitoring tool? 0 4 (28) 3 (21) 3 (21) 4 (28)

BP; blood pressure, SMBP; self-measured blood pressure monitoring

Percentages may not add up to 100% across a row due to rounding.

Of the 39 physicians who completed the initial survey, 18 agreed to discuss their experience with hypertension management in more detail. Of these 18 physicians, 14 physicians completed the semi-structured interviews between Dec 2019 and July 2020. These physicians had similar responses to the survey questions for satisfaction with BP control, and use of out of clinic BP monitoring. As adequacy of response did not seem complete for some domains (e.g., knowledge), we recruited three additional physicians to reach saturation at 17. Of the 17 physicians who completed the interview, 15 were women; eight were from the Department of Internal Medicine, and nine from the Department of Family Medicine. Three specialized in geriatrics (one from Internal medicine, and two from Family Medicine). The mean age of the respondents was 47.3±12.2 years, similar to the mean age of all PCPs in the health system (47.6±12.6 years). A majority had at least 10 years of clinical experience. Most were White, two were Black and two were Asian, similar to the racial/ ethnic demographics of all primary care physicians in the health system (81.4% White, 7.7% Asian, 4.5% Black, 2.6% two or more races and 3.9% unknow or not listed).

Interviews varied in length and lasted approximately 30–45 minutes. Knowledge, beliefs, and attitudes of physicians towards using SMBP are summarized in Tables 13 with direct quotes from the interviews categorized under the three BCW groups, motivation, opportunity, and capabilities.

Table 3. Common themes and relevant quotes illustrating barriers and facilitators for opportunity.

TDF Domains Common Themes noted in Interviews Exemplary Quotes grouped as Barriers and Facilitators
Social Influences SMBP is driven by evidence and not behavior of colleagues. If there was a study that showed that ambulatory blood pressure monitoring really doesn’t help in the long term then I would stop pushing…
If there was data, it would probably sway me. But I don’t know just on other people’s actions if I would change.
I guess it would depend on why they’re using it less and less and if they are aware of some evidence that came out that I’m not aware of…
Not unless there was some data that showed me that [SMBP] wasn’t doing any good.
Environmental Context and Resources Obtaining SMBP data from some patients can be hard. …there’s talk about encouraging patients to use the MyChart for uploading blood pressures and how it can be a valuable tool.…if the median age is 82, they are going to have more challenges than a younger population to even get access to [MyChart], so that’s a big challenge. But I think once someone is on-board, once they have kids that maybe on-board for them, it’s a great tool, but it’s just giving them that access.…there’s a push for us to get all of our patients enrolled in MyChart but the older adults just, I get them enrolled and they can’t follow through on it.
Lack of workflow support is a common barrier to SMBP. I’m a pretty good person from a patient standpoint to look at that data and act on it but I don’t have that support. . . .
I can always use more support but yeah, I feel like I’m kind of old fashioned. I like to look at things myself. Well, no, it might be nice to have more support in that.
Obviously if the pharmacist is doing it, it would take some of the burden off of the clinician from having to do it.
Another barrier is the cost of BP cuffs. If their insurance pays for the blood pressure cuff, I will prescribe it so that they can get it paid for by the insurance company.
The cost is all on the patient…Insurance isn’t going to pay for a blood pressure cuff, and I don’t have a free blood pressure cuff that I can give the patient…
Accuracy of home BP cuffs and method of measuring BP is a concern. … there’s a fair amount of worry that the information may be inaccurate because the machines aren’t good, or they don’t know how to use them and I still have that problem.• We just had a patient come in. She was obese. She was using the cuff that was provided with the device and it was too small for her arm, so they were very inaccurate readings. That’s why I always have them bring it in, because that stuff happens…not being able to always trust what the home values are I guess whether it’s ‘I’m not sure about the device’ or ‘I’m not sure how the patient is doing it and that kind of thing’ are big barriers.
Changes to guidelines influence use of SMBP. I would say the more recent guidelines emphasize home blood pressure monitoring, and that has changed my practice
Now I think if there was evidence behind [not doing home blood pressure monitoring] then that would sway me.
I think the new ones over the last year or two promote home blood pressure monitoring.

PCP; primary care physician, SMBP; self-measured blood pressure monitoring.

Motivation

Within the TDF domain of Motivation and Goals, we asked if increasing incentives- financial, work Relative Value Units or clinical time allocated- would increase motivation for SMBP implementation. Physician opinions were mixed. A few physicians were aware of the health systems participation in pay for quality initiatives such as Comprehensive Primary Care Plus (CPC+), a CMS program, that provides financial incentives for improving primary care delivery [50], and felt motivated to use SMBP. Of the physicians who were not aware of these programs, responses regarding the motivating nature of incentives varied greatly. Most indicated that incentives did motivate them. Others felt that these incentives, although helpful, may not be motivating enough to outweigh the logistic problems with SMBP as “barriers will probably still exist” (Table 2, motivation and goals). Improvement in hypertension management with SMBP and considering SMBP a part of their duties as a physician served as motivators for some.

Table 2. Common themes and relevant quotes illustrating barriers and facilitators for motivation.

TDF Domains Common Themes noted in Interviews Exemplary Quotes grouped as Barriers and Facilitators
Motivation and Goals Having incentives for SMBP can motivate PCPs. …all the work that’s done in-between office visits currently is not reimbursed, so having some reimbursement for that kind of work would be helpful.—I think one of the things that motivates people and also doctors the most is incentives.
However, some believed incentives alone would not be enough to overcome the barriers. So, I don’t think physician incentives really play a role. Patient incentives—now, that’s a different story.
I think the same barriers will probably still exist though.
Beliefs about Consequences SMBP make more BP readings available to physicians, improving their ability to manage hypertension. …trying to get their blood pressure down, that’s when I’ll say hey, why don’t you measure your blood pressure readings over five different readings over a period of time with more intensive home blood pressure monitoring.
I feel that sometimes [SMBP] keeps me from adjusting the medicines unnecessarily when their readings in the clinic are high.
…I ask them to monitor at home just because we get more data that way. 
SMBP is more accurate than in-clinic BP and can help with managing white coat hypertension. …they’re more relaxed at home, and so whenever they see me maybe their blood pressure is a little bit high. . . .
Or some patients have white coat hypertension, which it does help.
I think for white coat hypertension, it’s a very helpful tool to have those home readings.
…but more optimistic about the information I can get from those readings to be able to make reasonable change for that patient
If it is elevated in the clinic then making a decision about whether or not to start medication and diagnosing hypertension [is hard]…
Emotion SMBP is helpful but is stressful and burdensome. …I’m always hopeful that [SMBP] will be helpful. but I wouldn’t say it does not make me feel stressed at all.
I probably feel more hopeful than anything that they’ll take action and take a little responsibility for their blood pressure
…because it is kind of a burden.
Social or Professional Role and Identity Clinic staff other than physicians can help, but physician involvement is necessary with some aspects of hypertension management. I think a team-based approach is definitely the way the future is going…the pharmacist for sure, nurse practitioner just fine. RN would be–a trained RN would be fine. And probably a trained LPN would probably be reasonable.
It could be done by a nurse practitioner or pharmacist.
Although they’re pharmacists, they would know about interactions probably more than physicians do. But as far as the medical interactions, meaning how is this going to affect their memory loss, how is this going to affect their urination, how is this going to affect their quality of life, how is this going to affect their COPD, how will these medications affect their other illnesses, so I think that’s the physician’s perspective.
I think there are some things that are specific conditions that you learn in medical school and residency trainings…
I think we cannot minimize the role of the physician. I mean after having gone through med school. . .
…hypertension does not always have to be an isolated condition. It can be kind of a combination of so many things. Pharmacists I imagine would be able to know maybe medication interaction and see that a medicine is doing that but…I don’t think you can replace the physician’s knowledge.
I think at this point there’s enough guidelines and everything that a nurse or a nurse practitioner or a pharmacist would be able to manage …as long as there were proper protocols within those guidelines that if it got out of whack, it then resorted back to me.
Beliefs about Capabilities SMBP is underutilized. I think we don’t get as many people as we would like. So yes, I think it’s underutilized. I don’t think it’s because people are not prescribing it; I think it’s because of the barriers for people to do it.
I think we still don’t do enough of it.

PCP; primary care physician, SMBP; self-measured blood pressure monitoring, COPD; chronic obstructive pulmonary disease.

Under Beliefs about Consequences, physicians believed that SMBP yields more BP readings to manage hypertension, and that SMBP helps diagnose and manage white coat hypertension. These beliefs and consequences reinforced the use of SMBP in the majority of physicians and were facilitators for SMBP (Table 1, beliefs about consequences). Despite these benefits, all physicians explicitly believed that SMBP is being underutilized. The most common explanation for underutilization was the barriers outweighing the motivating consequences (Table 1, beliefs about capabilities). These barriers, (explicitly addressed under Opportunity) created reluctance to use SMBP despite the evidence and motivating consequences.

Within the TDF domain of Emotion, most physicians indicated positive emotions for SMBP. Common emotions included feeling hopeful and optimistic about improved care. Physicians indicated that their patients also expressed similar emotions with SMBP. However, some respondents expressed frustration and stress. Although the increased number of BP readings with SMBP helped with improved BP, the overwhelming number of readings and other patient-care related issues that arise with SMBP resulted in these negative emotions (Table 2, emotion).

Under social or professional role and identity, we explored if other health care workers may be suited to manage or assist with SMBP. Physicians had different degrees of belief in non-physician patient care team members being able to manage SMBP (Table 2, social or professional role and identity). Nearly all respondents indicated that hypertension management through SMBP could be assisted, or in some cases performed completely by non-physician patient care team members such as registered nurses, nurse practitioners, and clinical pharmacists. A few physicians felt that non-physician health care workers do not receive adequate training in managing hypertension. These physicians were also motivated to use SMBP themselves, as they perceived SMBP to fall under their job as a physician. However, most felt that with some additional training, assistance from other health care workers would be helpful in SMBP.

These opinions were closely linked to beliefs about capabilities, where physicians felt that SMBP is a useful tool for managing hypertension, but is underutilized due to lack of workflow strategies and other logistical barriers. Assistance from non-physician team members could help increase SMBP utilization and improve patient outcomes.

Opportunity

Physicians saw an opportunity for SMBP. Under Social Influences, most physicians were influenced by published evidence backing SMBP. Only a change in evidence, and not the behavior of their colleagues, would make them not use SMBP (Table 3, social influences). Some PCPs found it concerning if others did not use SMBP.

Three main sub-themes were identified under environmental context and resources. 1) Patient portals such as MyChart are used to receive SMBP readings from patients. Although all respondents used digital tools for SMBP to a varied extent, a common barrier perceived by all physicians was the technological capabilities of patients. Many felt that older patients have trouble using these digital tools. Paper logs are a common alternative. When patients can use digital tools, most physicians found patient portals to be helpful. Technical issues with the patient portal varied depending on the preferences of individual respondents, but MyChart was generally well accepted (Table 3, environmental context and resources). 2) Another barrier commonly identified was lack of workflow support. The incoming SMBP data can be overwhelming; the number and frequency of readings per patient varied. A common problem was lack of time needed to review and act on the BP readings as there was no specific time allocated for these tasks. Several physicians thought that involving other team members such as registered nurses, nurse practitioners and clinical pharmacists could address this barrier and reduce physician stress (Table 3, environmental context and resources). 3) The cost and accuracy of home BP cuffs and the method of measuring BP were also concerns among nearly all respondents (Table 3, environmental context and resources). Alternative options to overcome this barrier included obtaining cuffs through programs assisting with free BP cuffs or using pharmacies that offer BP cuff access for the general public. Accuracy of home BP cuffs was also a widely discussed barrier noted by nearly all respondents. Causes of inaccuracy could be related to calibration of the machine, wrist cuffs, improper cuff sizes or technique. Some physicians asked patients to bring home BP cuffs into the clinic to compare readings to detect these inaccuracies (Table 3, environmental context and resources).

Capabilities

Although physician participants reported no personal knowledge deficits for SMBP, they recognized the high skill level necessary for hypertension management, discussed under the Skills domain in Table 4. Physicians mentioned that knowledge of hypertension guidelines and anti-hypertensives alone were insufficient to manage hypertension and knowledge about patients’ complete medical history, comorbidities and lifestyle were also important (Table 4, skills) to understand the cause of hypertension and appropriately manage it.

Table 4. Common themes and relevant quotes illustrating barriers and facilitators for capabilities.

TDF Domains Common Themes noted in Interviews Exemplary Quotes grouped as Barriers and Facilitators
Skills A holistic approach with knowledge of guidelines, disease processes, medications and comorbidities are needed to manage hypertension. You’d have to have baseline knowledge of the disease and the therapeutic measures, and so you’d have to know the protocols. But you’d also have to be able to think critically, and problem solve, and recognize and understand the exceptions to the rules.
I think you have to have some background knowledge of all of those things—the physiology, the pathophysiology, the pharmacology—and then also be able to look at all of those things in the context of the patient and the patient lifestyle and the patient’s comorbid conditions so that you can come up with a treatment plan that’s going to work for that individual patient.
If there is a patient just has plain hypertension and nothing else is going on, that’s fine. But if they also have lupus, if they also have a history of a stroke, there are other things to take into account.
You would need knowledge of the medications, the guidelines, and yeah, side effects, interactions. There’s certainly a large knowledge that’s needed to be able to manage somebody’s blood pressure.
Clinic staff other than physicians may not have all the skills needed for managing hypertension but can be trained to manage hypertension. I think that they all have adequate training. The pharmacist may know more about medications. We, in our clinic can now refer to a pharmacist to check in on blood pressure as well as other things, but then we also have the nurse protocol, and so all of them are adequately trained and you could say that a RN nurse can do it.
I don’t know if they have the skills right now but I think they could be trained. I’m pretty sure they could be trained. We’re using people who are PharmDs and some of them have done residencies.…I think if a nurse can be taught to change medication based on protocol, that the pharmacist shouldn’t have any problem at all.
Communication, I guess, is another skill… I think there’d have to be a period of training.
I think there are some things that are specific conditions that you learn in medical school and residency trainings that a pharmacist just doesn’t have the training in so I think there would need to be collaboration and oversight with a provider in certain cases…
My experience has been that [pharmacists] are knowledgeable about guidelines, medications, side effects. I think the only area that they would not excel in would maybe be looking at the whole picture and knowing the patient individually.
I don’t know that they could manage all the comorbidities and other things that complicate hypertension and all the other preventative things that need to be going along with it, because it’s not their training, but from a strictly medication-data management, side-effects management, they could probably do okay.
Behavioral Regulation Strategies for SMBP vary among PCPs. I always ask the patient if they have a blood pressure cuff that they use at home, and we talk a little bit about what kind of cuff if they have one. If they have one, we talk about appropriate ways to take the blood pressure…
Some patients who do not have a cuff and I think are unlikely to purchase one, I either ask them to go to the drugstore and get it checked or come back to our clinic for a nurse visit to have it checked.
If my patients are more elderly, they’ll usually record them at home and then call my nurse with readings and she’ll just type them into a note so I can review them, but a lot of my younger patients are pretty technologically savvy and they’ll just use the one on MyChart.
But I’ve had multiple patients who have said that they can’t afford it. So, then I often will recommend that they go to a local CVS or Walgreens or a pharmacy and have their blood pressure monitoring.
Memory, Attention, and Decision Processes PCPs rely on in-clinic BP for hypertension management. I follow the guidelines and everything, so in general 140/90, if it touches that then we start talking about medications and everything.
If they come in, though, and their blood pressure is already 180/100, then I’ll go straight to medication in addition to the lifestyle modifications.

PCP; primary care physician, SMBP; self-measured blood pressure monitoring, RN; registered nurse.

All respondents stated that ancillary medical staff possess some necessary skills and can be further trained to manage hypertension by themselves or assist physicians (Table 4, skills). Nurse practitioners, physician assistants, and pharmacists were specifically discussed. Some physicians indicated that although these professionals may not possess deep knowledge of physiology and disease process- skills acquired in medical school; they can be trained to manage hypertension in most patients. Nurses, nurse practitioners and physician assistants may not have a deep knowledge of anti-hypertensives and hypertension guidelines. Pharmacists on the other hand, may have the knowledge of medications; their doses, side effects and drug interactions, but may not be skilled at a complete clinical assessment or have the expertise needed for considering different aspects of patients’ medical problems and lifestyle when considering treatment options.

Under Behavioral Regulation, respondents elaborated on differences in using SMBP for managing hypertension. Several mentioned that if their patients are not able to obtain BP cuffs, they ask them to use alternative methods such as pharmacies for recording out of clinic BPs. If transferring SMBP readings digitally is a barrier for patients, some physicians use paper logs to obtain SMBP readings (Table 4, behavioral regulation).

The majority of physicians reported different triggers and thresholds for using SMBP in their clinics. These are presented under Memory, Attention, and Decision Processes (Table 4, memory, attention, and decision processes). Initiation of SMBP for a patient depended on several factors that varied between physicians. Similarly, the threshold for modification of the treatment regimen and the regimen itself also varied. Although the majority followed guidelines for decision making, management approach was often individualized based on patients’ age or other factors (Table 4, memory, attention, and decision processes).

Discussion

We interviewed PCPs, key stakeholders in hypertension management [51], to identify their experiences, beliefs and perceptions toward SMBP. Physicians believed SMBP can improve hypertension management but identified barriers to successful implementation of SMBP. Most believed that it is difficult to adjust anti-hypertensives based on in-clinic BP measurements, that SMBP provides increased number of BP readings, and that SMBP makes it easier to separate reliable BP measurements from situational fluctuations such as white coat hypertension and to determine whether a change in anti-hypertensives is warranted. Despite their beliefs in the strong evidence behind SMBP, there was underutilization of SMBP due to logistical barriers and lack of resources and trained personnel to help with SMBP. They also identified ways to systematically address these barriers to increase adoption of SMBP. Through this study, we aimed to understand physician perspectives so factors inhibiting their use of SMBP can be combined with evidence-based guidelines to develop effective strategies to implement SMBP.

Out of clinic BP, both ambulatory BP and SMBP, are recommended in hypertension guidelines. We focused on SMBP instead of ambulatory BP monitoring as ambulatory BP monitoring is often not well tolerated by patients, more resource intensive, available in specialized clinics only and not easily scalable [19]. Prior studies in [32, 52] or outside the US [5355] show similar barriers for SMBP despite differences in health policies. Physicians lack appropriate tools and support needed for SMBP, and the use of SMBP remains rather haphazard in clinical practice. Despite similar barriers, use of SMBP is lower in the US- 67% in Spain and 58% in UK compared to 20–50% in the US [32, 56, 57]. In contrast to surveys or questionnaires used in previous studies [32, 52, 53, 55], we used semi-structured interviews to allow for more detailed conversations about the barriers and facilitators. This approach, which is standard in the field of implementation science, allowed us to explore the influence of a comprehensive set of potential determinants, not previously explored in other studies.

Our study identified multiple barriers at different levels with the current systems and policies that prohibit successful implementation of SMBP. Under motivation we found that increased workload without additional support staff to train patients on SMBP and follow SMBP readings in an already busy clinic, lack of well-defined protocols for SMBP, lack of detail in the guidelines for SMBP, and cost of BP cuffs were common barriers. New CPT codes 99473 and 99474 introduced in year 2020 might help with physician incentives but are not likely to solve these barriers. Physicians experienced a high degree of stress and perceived burden in managing SMBP. Lack of physician incentives has been identified by other studies but was not a critical barrier in our study. Instead increasing patient engagement and incentives may be more important. Under opportunities, the respondents emphasized barriers we attributed to the TDF domain of ‘environmental context and resources’. They mentioned that clinical decision support could help- however, no formal algorithm or guidelines are available for widespread implementation. Lack of interdisciplinary teamwork, including training and support of other staff to fulfill the role expectations that physicians believe is necessary was a major barrier. Further, physicians helped highlight barriers at an organizational level. Even though the health system is ideally suited for SMBP, with an excellent electronic medical record system, high patient portal use, physicians who believe in SMBP, largely insured patients, and ongoing institutional initiatives to improve BP control, very few physicians routinely use SMBP (Table 1). Incentives by insurers [50] have prioritized improving hypertension management by health systems and health systems have incorporated tools to facilitate reporting of SMBP. However, our study suggests that financial incentives, while helpful, may only be part of the solution. Few physicians in our study used the tools provided by the health system, suggesting the need for better strategies to monitor SMBP. Our interviews indicated that health system approaches (such as use of a patient portal for entering SMBP) may not be ideal solutions and present additional barriers, particularly for older adults. Under capabilities we found that physicians would be more comfortable having additional staff assist with SMBP after they had some additional SMBP-specific training. Prior studies indicate that nurses or pharmacists can manage SMBP, but our study indicated that they might need additional training to fulfil these roles. Patients seen in clinics often have more complex medical issues than participants in clinical trials (where patients with multimorbidity are often excluded), and management of SMBP in the real world may need more training and expertise.

Compared to previous studies using surveys and questionnaires, our interviews also helped us obtain more information on major facilitators for SMBP. Under motivation we found that physicians strongly believed in positive outcomes associated with SMBP over current methods to manage BP, and desired to incorporate SMBP in their practice. Physician engagement in SMBP is important as adherence to SMBP by patients is significantly higher if their physicians recommend it [51, 58]. Under opportunities, we confirmed that successful implementation of SMBP will require a team approach, efficient data systems, performance assessments, and standardized protocols along with well thought out strategies; all of which are not easy without the support of the organization [5961]. Under capabilities we identified the areas where additional health care professionals can be trained to develop a multi-disciplinary team to implement SMBP. Our study indicates that environmental restructuring and enablement, through adding trained support to care team, physician teams can educate patients on cuff size, the correct method for SMBP, and lifestyle modifications to ultimately improve patient engagement and empowerment [19].

With stakeholders such as patients, physicians, health systems, and insurers interested in adopting SMBP, practical scalable strategies are needed. A systematic implementation science- based approach can integrate evidence-based SMBP in the real world. With the strong evidence backing SMBP, more efforts need to be placed in testing pragmatic effectiveness and implementation studies incorporating education and clear protocols for interpretation and management of SMBP [62].

A limitation of this study is inclusion of PCPs from a single health system. However, this also helped with detailed interviews and meaningful discussions that can lead to actionable steps towards developing an implementation strategy. Moreover, the respondents were a mix of both academic and community physicians from the largest health system in the area. Most of our respondents (88%) were women, limiting generalizability. Our interviews were voluntary and non-incentivized, which could have limited participation. However, the voluntary nature of the interviews enabled participation of physicians committed to hypertension control. Their responses confirmed and expanded on those of other physicians across the world [32, 5255]. With open-ended questions in the interviews, we were able to identify several facilitators for developing practical strategies to implement SMBP. We did not specifically ask about BP device loaner programs or the new CPT codes 99473 and 99474 introduced in year 2020 to help SMBP. However, none of the physicians mentioned the codes, which might indicate that use of the codes may not be widespread yet.

In conclusion, understanding physician perspective and reasons for their inability to implement SMBP (despite their belief in SMBP) is essential to develop and successfully implement strategies for SMBP. PCPs feel that SMBP is a useful tool to manage hypertension that is underutilized due to lack of workflow, support, patient education and engagement, team training, protocols, and financing of BP cuffs. These barriers can be addressed by using efficient, user-friendly technology to obtain SMBP readings and developing a collaborative team specifically trained for SMBP. Some of the cost savings in healthcare utilization with improved BP control can be directed towards purchase of BP cuffs by health systems or insurers.

Supporting information

S1 File. Identifying barriers and facilitators to home BP monitoring using the theoretical domains framework.

(DOCX)

Acknowledgments

We are thankful to all participating physicians.

Data Availability

All relevant data are within the paper.

Funding Statement

The study was supported by the National Institutes of Health K23 AG055666 (AG), R61 AG068483 (AG and JB) and P20GM130423 (SE).

References

  • 1.Bundy JD, Li C, Stuchlik P, Bu X, Kelly TN, Mills KT, et al. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis. JAMA Cardiol. 2017;2(7):775–81. doi: 10.1001/jamacardio.2017.1421 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine. 2015;373(22):2103–16. doi: 10.1056/NEJMoa1511939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Lancet. 1997;350(9080):757–64. doi: 10.1016/s0140-6736(97)05381-6 [DOI] [PubMed] [Google Scholar]
  • 4.Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al. Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly. Hypertension. 2010;56(2):196–202. doi: 10.1161/HYPERTENSIONAHA.109.146035 [DOI] [PubMed] [Google Scholar]
  • 5.Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. Jama. 1991;265(24):3255–64. [PubMed] [Google Scholar]
  • 6.Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. The Lancet. 2009;374(9689):525–33. doi: 10.1016/S0140-6736(09)61340-4 [DOI] [PubMed] [Google Scholar]
  • 7.Whelton Paul K, Carey Robert M, Aronow Wilbert S, Casey Donald E, Collins Karen J, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. doi: 10.1161/HYP.0000000000000065 [DOI] [PubMed] [Google Scholar]
  • 8.Khatib R, Schwalm J-D, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies. PLOS ONE. 2014;9(1):e84238. doi: 10.1371/journal.pone.0084238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bress AP, Kramer H, Khatib R, Beddhu S, Cheung AK, Hess R, et al. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey). Circulation. 2017;135(17):1617–28. doi: 10.1161/CIRCULATIONAHA.116.025322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Adams JM, Wright JS. A National Commitment to Improve the Care of Patients With Hypertension in the US. JAMA. 2020. doi: 10.1001/jama.2020.20356 [DOI] [PubMed] [Google Scholar]
  • 11.Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 1977;237(3):255–61. [PubMed] [Google Scholar]
  • 12.Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, et al. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999–2000 to 2017–2018. Jama. 2020;324(12):1190–200. doi: 10.1001/jama.2020.14545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-Measured Blood Pressure Monitoring in the Management of Hypertension: A Systematic Review and Meta-analysis. Annals of Internal Medicine. 2013;159(3):185–94. doi: 10.7326/0003-4819-159-3-201308060-00008 [DOI] [PubMed] [Google Scholar]
  • 14.Zarnke KB, Feagan BG, Mahon JL, Feldman RD. A Randomized Study Comparing a Patient-Directed Hypertension Management Strategy With Usual Office-Based Care*. American Journal of Hypertension. 1997;10(1):58–67. doi: 10.1016/s0895-7061(96)00305-6 [DOI] [PubMed] [Google Scholar]
  • 15.Stahl SM, Kelley CR, Neill PJ, Grim CE, Mamlin J. Effects of home blood pressure measurement on long-term BP control. American Journal of Public Health. 1984;74(7):704–9. doi: 10.2105/ajph.74.7.704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857–67. doi: 10.1001/jama.299.24.2857 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Soghikian K, Casper SM, Fireman BH, Hunkeler EM, Hurley LB, Tekawa IS, et al. Home Blood Pressure Monitoring: Effect on Use of Medical Services and Medical Care Costs. Medical Care. 1992;30(9):855–65. [PubMed] [Google Scholar]
  • 18.Arrieta A, Woods JR, Qiao N, Jay SJ. Cost-benefit analysis of home blood pressure monitoring in hypertension diagnosis and treatment: an insurer perspective. Hypertension. 2014;64(4):891–6. doi: 10.1161/HYPERTENSIONAHA.114.03780 [DOI] [PubMed] [Google Scholar]
  • 19.Shimbo D, Artinian Nancy T, Basile Jan N, Krakoff Lawrence R, Margolis Karen L, Rakotz Michael K, et al. Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42–e63. doi: 10.1161/CIR.0000000000000803 [DOI] [PubMed] [Google Scholar]
  • 20.Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63(4):675–82. doi: 10.1161/HYPERTENSIONAHA.113.02741 [DOI] [PubMed] [Google Scholar]
  • 21.George J, MacDonald T. Home Blood Pressure Monitoring. Eur Cardiol. 2015;10(2):95–101. doi: 10.15420/ecr.2015.10.2.95 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Traget:BP. Americal Medical Association (AMA) and American Heart Association (AHA). https://targetbp.org/.
  • 23.Million Hearts. Centers for Disease Control and Prevention. https://millionhearts.hhs.gov/.
  • 24.Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018;39(33):3021–104. doi: 10.1093/eurheartj/ehy339 [DOI] [PubMed] [Google Scholar]
  • 25.Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–20. doi: 10.1258/jrsm.2011.110180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychology. 2015;3(1):32. doi: 10.1186/s40359-015-0089-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi: 10.1186/1748-5908-6-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cane J O ’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37. doi: 10.1186/1748-5908-7-37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wensing M, Oxman A, Baker R, Godycki-Cwirko M, Flottorp S, Szecsenyi J, et al. Tailored implementation for chronic diseases (TICD): A project protocol. Implementation Science. 2011;6(1):103. doi: 10.1186/1748-5908-6-103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Carter EJ, Moise N, Alcántara C, Sullivan AM, Kronish IM. Patient Barriers and Facilitators to Ambulatory and Home Blood Pressure Monitoring: A Qualitative Study. Am J Hypertens. 2018;31(8):919–27. doi: 10.1093/ajh/hpy062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Doane J, Buu J, Penrod MJ, Bischoff M, Conroy MB, Stults B. Measuring and Managing Blood Pressure in a Primary Care Setting: A Pragmatic Implementation Study. J Am Board Fam Med. 2018;31(3):375–88. doi: 10.3122/jabfm.2018.03.170450 [DOI] [PubMed] [Google Scholar]
  • 32.Kronish IM, Kent S, Moise N, Shimbo D, Safford MM, Kynerd RE, et al. Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States. J Am Soc Hypertens. 2017;11(9):573–80. doi: 10.1016/j.jash.2017.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Reschovsky JD, Hadley J, Landon BE. Effects of compensation methods and physician group structure on physicians’ perceived incentives to alter services to patients. Health Serv Res. 2006;41(4 Pt 1):1200–20. doi: 10.1111/j.1475-6773.2006.00531.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Racine DP. Reliable effectiveness: a theory on sustaining and replicating worthwhile innovations. Adm Policy Ment Health. 2006;33(3):356–87. doi: 10.1007/s10488-006-0047-1 [DOI] [PubMed] [Google Scholar]
  • 35.Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi: 10.1186/1748-5908-4-50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jackson SL, Ayala C, Tong X, Wall HK. Clinical Implementation of Self-Measured Blood Pressure Monitoring, 2015–2016. Am J Prev Med. 2019;56(1):e13–e21. doi: 10.1016/j.amepre.2018.06.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Woolsey S, Brown B, Ralls B, Friedrichs M, Stults B. Diagnosing Hypertension in Primary Care Clinics According to Current Guidelines. J Am Board Fam Med. 2017;30(2):170–7. doi: 10.3122/jabfm.2017.02.160111 [DOI] [PubMed] [Google Scholar]
  • 38.Phillips CJ, Marshall AP, Chaves NJ, Jankelowitz SK, Lin IB, Loy CT, et al. Experiences of using the Theoretical Domains Framework across diverse clinical environments: a qualitative study. J Multidiscip Healthc. 2015;8:139–46. doi: 10.2147/JMDH.S78458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Birken SA, Presseau J, Ellis SD, Gerstel AA, Mayer DK. Potential determinants of health-care professionals’ use of survivorship care plans: a qualitative study using the theoretical domains framework. Implementation science: IS. 2014;9:167–. doi: 10.1186/s13012-014-0167-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ellis SD, Geana M, Mackay CB, Moon DJ, Gills J, Zganjar A, et al. Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices. Urologic oncology. 2019;37(8):529.e9–.e18. doi: 10.1016/j.urolonc.2019.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nelson-Brantley H, Buller C, Befort C, Ellerbeck E, Shifter A, Ellis S. Using Implementation Science to Further the Adoption and Implementation of Advance Care Planning in Rural Primary Care. Journal of Nursing Scholarship. 2020;52(1):55–64. doi: 10.1111/jnu.12513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ellis S, Geana M, Griebling T, McWilliams C, Gills J, Stratton K, et al. Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices. Trials. 2019;20(1):578. doi: 10.1186/s13063-019-3658-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Birko S, Dove ES, Ozdemir V. Evaluation of Nine Consensus Indices in Delphi Foresight Research and Their Dependency on Delphi Survey Characteristics: A Simulation Study and Debate on Delphi Design and Interpretation. PLoS One. 2015;10(8):e0135162. doi: 10.1371/journal.pone.0135162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hsu C, Sandford BA. The Delphi Technique: Making Sense of Consensus. Practial Assessment, Research and Evaluation. 2007;12(10):1–8. [Google Scholar]
  • 45.Hsu C-C, Sandford BA. Minimizing Non-Response in the Delphi Process: How to Respond to Non-Response. Practial Assessment, Research and Evaluation. 2007;12(17). [Google Scholar]
  • 46.Ellis SD, Kimminau K., Jones E., Thrasher J.B. De-Implementing Curative Therapy in Low-Risk Prostate Cancer: Preliminary Evidence of Urologists’ Unlearning. Society for Medical Decision Making Annual Meeting. Vancouver, British Columbia; 2016. [Google Scholar]
  • 47.Zganjar A, Mackay C, Petty L, Geana M, Gills J, Griebling T, et al. LEARN-INFORM-RECRUIT: Increasing the Offer of Urologic Cancer Trials in Community Practice. South Central Section of the American Urological Association. Naples, FL; 2017. [Google Scholar]
  • 48.Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. doi: 10.1186/s13012-017-0605-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Råheim M, Magnussen LH, Sekse RJ, Lunde Å, Jacobsen T, Blystad A. Researcher-researched relationship in qualitative research: Shifts in positions and researcher vulnerability. Int J Qual Stud Health Well-being. 2016;11:30996. doi: 10.3402/qhw.v11.30996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Centers for Medicare and Medicaid Services. https://innovation.cms.gov/innovation-models/comprehensive-primary-care-plus.
  • 51.Carrera PM, Lambooij MS. Implementation of Out-of-Office Blood Pressure Monitoring in the Netherlands: From Clinical Guidelines to Patients’ Adoption of Innovation. Medicine (Baltimore). 2015;94(43):e1813. doi: 10.1097/MD.0000000000001813 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Cheng C, Studdiford JS, Diamond JJ, Chambers CV. Primary care physician beliefs regarding usefulness of self-monitoring of blood pressure. Blood Press Monit. 2003;8(6):249–54. doi: 10.1097/00126097-200312000-00005 [DOI] [PubMed] [Google Scholar]
  • 53.Logan AG, Dunai A, McIsaac WJ, Irvine MJ, Tisler A. Attitudes of primary care physicians and their patients about home blood pressure monitoring in Ontario. J Hypertens. 2008;26(3):446–52. doi: 10.1097/HJH.0b013e3282f2fdd4 [DOI] [PubMed] [Google Scholar]
  • 54.Jones MI, Greenfield SM, Bray EP, Hobbs FR, Holder R, Little P, et al. Patient self-monitoring of blood pressure and self-titration of medication in primary care: the TASMINH2 trial qualitative study of health professionals’ experiences. Br J Gen Pract. 2013;63(611):e378–85. doi: 10.3399/bjgp13X668168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Fletcher BR, Hinton L, Bray EP0, Hayen A, Hobbs FR, Mant J, et al. Self-monitoring blood pressure in patients with hypertension: an internet-based survey of UK GPs. The British journal of general practice: the journal of the Royal College of General Practitioners. 2016;66(652):e831–e7. doi: 10.3399/bjgp16X687037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Liyanage-Don N, Fung D, Phillips E, Kronish IM. Implementing Home Blood Pressure Monitoring into Clinical Practice. Curr Hypertens Rep. 2019;21(2):14. doi: 10.1007/s11906-019-0916-0 [DOI] [PubMed] [Google Scholar]
  • 57.Tang O, Foti K, Miller ER, Appel LJ, Juraschek SP. Factors Associated With Physician Recommendation of Home Blood Pressure Monitoring and Blood Pressure in the US Population. Am J Hypertens. 2020;33(9):852–9. doi: 10.1093/ajh/hpaa093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Ostchega Y, Zhang G, Kit BK, Nwankwo T. Factors Associated With Home Blood Pressure Monitoring Among US Adults: National Health and Nutrition Examination Survey, 2011–2014. Am J Hypertens. 2017;30(11):1126–32. doi: 10.1093/ajh/hpx101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Jaffe MG, Young JD. The Kaiser Permanente Northern California Story: Improving Hypertension Control From 44% to 90% in 13 Years (2000 to 2013). The Journal of Clinical Hypertension. 2016;18(4):260–1. doi: 10.1111/jch.12803 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program. JAMA. 2013;310(7):699–705. doi: 10.1001/jama.2013.108769 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Young A, Ritchey MD, George MG, Hannan J, Wright J. Characteristics of Health Care Practices and Systems That Excel in Hypertension Control. Prev Chronic Dis. 2018;15:E73. doi: 10.5888/pcd15.170497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Fletcher BR, Hinton L, Hartmann-Boyce J, Roberts NW, Bobrovitz N, McManus RJ. Self-monitoring blood pressure in hypertension, patient and provider perspectives: A systematic review and thematic synthesis. Patient Educ Couns. 2016;99(2):210–9. doi: 10.1016/j.pec.2015.08.026 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Bradford Dubik

17 Mar 2021

PONE-D-20-38491

Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study

PLOS ONE

Dear Dr. Gupta,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 28 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Bradford Dubik

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Furthermore, please also provide additional details in the Methods section on the validation of the questionnaire.

When reporting the results of qualitative research, we suggest consulting the COREQ guidelines: http://intqhc.oxfordjournals.org/content/19/6/349. In this case, please consider including more information on the number of interviewers, their training and characteristics; and please provide the interview guide used.”

LAS (Assoc Ed) 09/12/20 ***EO: please send back the following request and ping me with follow-up: “Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

3. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting study on the perspectives of primary care providers on barriers and facilitators to implementing SMBP. The authors use the theoretical domains framework (TDF) to organize the determinants, which has the potential to inform future interventions. Overall, while interesting, it's not clear that the findings are novel, generalizable or would add to the literature overall. I have included some recommendations for improving the study below.

Overall, the introduction is very well written and makes a good case for the effectiveness and importance of SMBP. It would be helpful to quantify and reference the conclusion that SMBP has not been widely implemented, particularly in the telemedicine era that we find ourselves.

The authors summarize several prior studies on the barriers/facilitators to SMBP implementation. It's not clear how their approach/focus on providers fills gaps in prior research. Have prior studies not examined provider perspectives? Is it clear that provider behavior is key to SMBP implementation?

The authors provide a good definition of the utility of implementation science, but should provide a rationale for their use of TDF/COMB/BCW as opposed to CFIR for example in examining provider based determinants in the methods section.

To really understand context, which is key to implementation science, more information is needed about the setting (urban, rural, large, small, academic, integrated?).

The authors should include the start date of interviews. Did the authors assess pre/post covid changes in perspectives/attitudes?

How was the interview guide developed. There are several examples of TDF interview guides in the literature. Did the authors explore each construct? What kinds of questions were posed of the participants (this should be included in the supplementary materials if possible)?

Reporting should align with COREQ https://www.equator-network.org/reporting-guidelines/coreq/

In the results section, the authors note that many participants did not use the patient portal to collect SMBP measurements. This is again why it's important to understand context. Is SMBP available in your setting? Is the SMBP data integrated into the EHR currently? This is important because if widely available/financed but not utilized, then there may be a way to tie this into prior literature suggesting that SMBP was impossible because of lack of EHR integration, etc.

Were there any differences (e.g., demographic) between individuals who agreed to participate in the interviews and those who did not?

In the motivation section, the interviewers note that they prompted PCPs to answer questions about incentives. Again are these questions that you added to the TDF interview guide?

To what degree did providers receive an introduction on SBMP prior to the interviews (i.e., the fact that nurse assisted SMBP has been shown to be particularly effective).

In the discussion, I found it difficult to tease apart whether/how their findings are different from prior research or how their theoretical approach added to prior literature. The utility of using BCW is that you can map to intervention functions/BCTs. Are they any that the authors can glean that should be tested in future research?

Do the authors have a sense for which one of the TDF constructs were the most salient (e.g, are underuse mostly driven by opportunity or motivation and less so capability?).

Reviewer #2: This manuscript, entitled “Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study”, is an important contribution to the literature for self-measured blood pressure monitoring. As the authors note, there is strong science behind the use of SMBP for hypertension management but we have yet to achieve widespread implementation in the U.S. due to a number of patient- and clinician-identified barriers. There are a few publications on barriers but this manuscript helps to shore up physician-identified barriers and facilitators for SMBP implementation.

Overall, this is a well-written piece, but it could benefit from some additional copy-editing (e.g. for missing hyphens in compound adjectives, at least one strange use of a semi-colon). A few copy edits of note:

• Pg 15 of PDF – under “Opportunity” paragraph, third row, delete “expected”.

• Pg 17 of PDF – “Under Behavioral Regulation…” paragraph, third line down, “recoding” should be changed to “recording”

• Table 1 – For the question “Please rate the appropriateness of alternative strategies for improving HTN management”, second to last column heading needs to be changed to “somewhat inappropriate”

• Table 2 – “HPBM” should be changed, at a minimum, to “HBPM” but better to change it to “SMBP” for consistency. (second column, first entry)

Some additional suggestions:

• Recommend editing your third paragraph in the background to mention home-blood pressure monitoring as follows: “Compared to in-clinic BP monitoring, out-of-office or self-measured blood pressure monitoring (SMBP), sometimes known as home blood pressure monitoring, …” I much prefer the term SMBP and much of the currently published literature uses this term but not all of it.

• In your background, you mention the Surgeon General’s support of SMBP (as a strategy from the recent Call to Action to Control Hypertension). Could also consider a sentence acknowledging how national initiatives like AMA/AHA’s TargetBP and CDC/CMS’s Million Hearts have been working for years on widespread implementation of SMBP but have not been able to make much headway.

• For generalizability purposes, this piece could greatly benefit from some additional contextual information about the respondents and their patient populations. For example, the authors provide some written demographic data about respondents (e.g. 15/17 women, 3 geriatricians, mix of both academic and community physicians) but it would be nice to have those data and additional data (age, race/ethnicity) in a table. Would also be nice to understand if any of these 17 key informants were among the physicians who supported SMBP or were they among those who had reservations about using it (from the survey)? Would also be helpful to have some ballpark estimation of what the respondents actual (and perceived if available) BP control rate is for their patient population, what percent of their population has HTN, etc. It would also be helpful to understand a little about the general patient population – e.g. low SES, inner city population; more affluent, mostly-white population. Physician perceptions of barriers and facilitators are skewed by the patients they serve.

• You mention CPC+ but it feels almost like a non sequitur. Consider talking more generally about pay-for-quality initiatives because CPC+ is just one of many initiatives in that space. If you want to call it out, perhaps add a citation. Likewise, you parenthetically mention “A Million Hearts Initiative”. Would recommend changing that to “The Million Hearts Initiative” (or more correctly just “Million Hearts”) and perhaps adding a bit more context or a citation there as well. Million Hearts is a major supporter of SMBP but as an initiative, in general, doesn’t pay for monitors. Were you referencing their work with NACHC/federally qualified health centers or work through departments of public health? Unclear. It is still very much a live initiative (i.e. hasn’t gone away) so additional clarity would be helpful.

• A potential limitation not noted is the fact that almost all respondents were women. While we don’t necessarily have any reason to believe women would have different perceptions about SMBP than men, it is fairly unusual for 88% of respondents in any study to be women and should at least be noted.

• Another potential limitation is, depending on your response to one of my questions above, the respondents were likely all supporters of SMBP so their barriers are already skewed towards people who trust SMBP. Responses would have differed if respondents included physicians who don’t use SMBP with their patients or who don’t trust the readings, etc.

• I would caution you in the future to separate the use of blood pressure kiosks (i.e. found in pharmacies/grocery stores) from SMBP performed on a patient’s own blood pressure monitor. Not a lot of evidence behind the former, lots behind the latter. If you discussed both of them equivalently with physicians in your interviews (the way it was denoted in the survey), that may have skewed their perceptions. May want to list this as a potential limitation.

• Future research is not noted but there seemed to be some gaps in in what was asked of these physicians. For example, what were their feelings about blood pressure device loaner programs (where health care settings bulk purchase devices and loan them out to patients on a temporary basis)? Were they aware of the new CPT codes that were introduced in 2020 that would reimburse clinicians one time to train patients on SMBP technique/perform device calibration (99473) and reimburse physicians up to monthly to receive SMBP readings, interpret, and combine into a patient’s care plan (99474)?

• References 30 and 46 appear to be the same reference.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Hilary K. Wall

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Aug 20;16(8):e0255578. doi: 10.1371/journal.pone.0255578.r002

Author response to Decision Letter 0


25 Apr 2021

We thank the editors and the reviewers for their thoughtful feedback and the enthusiasm reflected in their comments. We are also thankful for their suggestions which we believe have improved the manuscript. Our responses to the concerns are outlined below.

Editors comments:

1) Please include additional information regarding the survey or questionnaire used in the study. Please also provide additional details in the Methods section on the validation of the questionnaire. Please provide the interview guide used.

Response: Thank you for the comment. We have added the interview guide as supplementary data 1 and added more detail about the interview guide in the Methods section under a new sub section “The interview guide”. Consistent with determinant inquiry which is the current standard in the field of implementation science, we used a qualitative interview guide based on a theoretical framework of behavior change. Rather than using a validated survey instrument designed to elicit a population average from a representative sample of providers, we used a qualitative interview method that seeks to probe all potential determinants of behavior to uncover the range of potential determinants experienced by providers in the targeted intervention setting. This approach ensures that the intervention delivery context is accounted for in implementation strategies and is typically adapted to other contexts as needed during implementation.

2) Please consider including more information on the number of interviewers, their training, and characteristics

Response: We have provided additional detail regarding the number of interviewers and described his training (by Dr. Ellis, an experienced ethnographic interviewer), and characteristics under “Interviewers and data collection” in the methods section. We chose a “naive” interviewer to avoid influence of the interviewer in the responses by the “expert” primary care physicians.

Reviewer #1

1) It will be helpful to quantify and reference the conclusion that SMBP has not been widely implemented, particularly in the telemedicine era that we find ourselves.

Response: We agree. We have added a more recent reference #57 published in September 2020 indicating low use of SMBP. We agree that SMBP should be used more in the telemedicine era and are using telemedicine in our ongoing study on implementation of SMBP (NCT04585880). Our study showed that some of the technological features such as use of a patient portal to report SMBP have their own problems and may not be ideal solutions for SMBP. Although beyond the scope of this manuscript, in our SMBP implementation pragmatic trial (NCT04585880), we are finding that despite data suggesting that telemedicine can increase use of SMBP, barriers to SMBP persist. For example, many patients do not routinely check BP at home, do not report SMBP readings during their telehealth visits and continue to check BP incorrectly.

2) The authors summarize several prior studies on the barriers/facilitators to SMBP implementation. It's not clear how their approach/focus on providers fills gaps in prior research. Have prior studies not examined provider perspectives? Is it clear that provider behavior is key to SMBP implementation?

Response: Thank you. We have added some more clarification for findings that are new in our study. Unlike previous studies, we used semi-structured interviews instead of surveys or questionnaires. ‘This approach, which is standard in the field of implementation science, allowed us to explore the influence of a comprehensive set of potential determinants, not previously explored in other studies.’ As indicated in the interview guide (supplementary data 1), we were able to probe deeper into the barriers to SMBP implementation and identify the most critical barriers and their potential solutions. The interviews enabled 2-way conversations and relative advantages and disadvantages of one strategy over another. We were able to identify how strategies such as clinical decision-making tools, physician incentives and having more staff would be helpful. For example, even though pharmacists have shown to be able to manage SMBP, we found that physicians would be more comfortable having pharmacists or nurses assist with SMBP if they had some additional training. This is an important finding for implementing SMBP in clinics as patients might have more complex medical conditions than the selective participants of a clinical trial. We have added more detail in the discussion section to highlight the additional information obtained through this study.

While we do not believe that provider behavior is the sole cause of poor implementation of SMBP or the only contributor to its successful implementation, PCPs are one of the key stakeholders in implementation of SMBP and ‘understanding physician perspective and reasons for their inability to implement SMBP (despite their belief in SMBP) is essential to develop and successfully implement strategies for SMBP’. Prior studies (ref 51) have suggested that PCPs can greatly influence SMBP. Through our interviews, PCPs provided valuable information on facilitators for SMBP that helped us develop strategies for SMBP implementation.

3) It is unclear if these findings are generalizable.

Response: Qualitative research is not designed to be generalizable. Rather, the in-depth mode of inquiry used here seeks to identify the range of barriers experienced, potential solutions to overcome them, and modalities by which the solutions might be delivered most effectively. Because of the theoretical basis from which the approach is drawn, it is thought to be more efficient at identifying effective solutions which can be systematically adapted as the intervention is brought to scale in other care delivery contexts.

We included a mix of academic and community clinic physicians, who were trained at different institutions, from different departments and with different number of years in practice, creating a wide range of experience and perspectives across the key characteristics in which we expect the barriers to vary. Moreover, our results are also consistent with some of the previously identified barriers. The responses confirmed and expanded on those of other physicians across the world. From our clinical and research experience, and available data, these results appear to be generalizable, but will be confirmed in our ongoing randomized trial on implementation of SMBP (NCT04585880).

4) The authors provide a good definition of the utility of implementation science but should provide a rationale for their use of TDF/COMB/BCW as opposed to CFIR for example in examining provider-based determinants in the methods section.

Response: We chose the TDF/COMB/BCW among the popular determinant frameworks based on our substantial experience with the framework, its comprehensiveness of a full range of potential determinants, its thorough exploration of individual motivation pertinent to individual healthcare providers’ prescribing behavior (a construct less emphasized in CFIR), and its utility in combination with the BCW in implementation strategy selection (another feature which is not as robustly developed in CFIR). We have added this in the methods section.

5) To understand the context, more information is needed about the setting (urban, rural, large, small, academic, integrated?), SMBP availability, SMBP data integration into the EHR. This is important because if widely available/financed but not utilized, then there may be a way to tie this into prior literature suggesting that SMBP was impossible because of lack of EHR integration, etc.

Response: Thank you for this excellent point. We have added a section “Setting” under methods describing the health system and patient population it serves. This section also describes how PCPs can see the SMBP readings entered by the patients on the patient portal. With our interviews we learned that even with this EHR tool, SMBP is low. We have added this under discussion- ‘health system approaches (such as use of patient portal for entering SMBP) may not be ideal solutions and present additional barriers, particularly for older adults. Few physicians in our study used the tools provided by the health system, suggesting need for better strategies to monitor SMBP.’ Like many health systems, we currently do not have an integrated system to directly transfer BP readings from patients cuffs to our EHR. We are however studying this strategy in our current trial.

6) The authors should include the start date of interviews. Did the authors assess pre/post COVID changes in perspectives/attitudes?

Response: We added the interview dates under the results section. There were no changes in the respondent’s perception. There was however a gap in the interviews due to COVID-19. The study team resumed interviews in June 2020 via a phone vs in person meeting prior to COVID.

7) How was the interview guide developed? There are several examples of TDF interview guides in the literature. Did the authors explore each construct? What kinds of questions were posed of the participants (this should be included in the supplementary materials if possible)?

Response: We have added a section under ‘Methods’ devoted to the interview guide description, explaining how we developed the interview guide, and the range of domains and behaviors it covered. We have also added the interview guide as Supplementary data 1.

8) Reporting should align with COREQ https://www.equator-network.org/reporting-guidelines/coreq/

Response: As directed by the COREQ guidelines, we have added more detail about the interviewer, study procedures and analysis.

Under ‘interviewers and data collection’ section of the methods, we have added personal characteristics of the interviewer, his relationship with the respondents, training, and experience as well as the method of approach.

Under ‘conceptual framework,’ we have added the rationale for selecting the Theoretical Domains Framework.

We have added a new section entitled ‘setting’ which describes the institution at which the participants were drawn.

We have elaborated on the coding procedures in the ‘data analysis’ section.

9) Were there any differences (e.g., demographic) between individuals who agreed to participate in the interviews and those who did not?

Response: Since the initial survey (which had a question where physicians were asked if they were interested in participating in the interview) was anonymous, we are not able to analyze the difference between the two groups. However, we have added more detail on the respondents’ demographics and age comparison with all PCPs in the health system in the results section. The respondents varied in their clinical experience, age, and apparent race. We could not add the race comparison with the health system due to a lot of missing data.

10) In the motivation section, the interviewers note that they prompted PCPs to answer questions about incentives. Again, are these questions that you added to the TDF interview guide?

Response: The TDF includes financial incentives as a component of motivation and we routinely explore different intrinsic and extrinsic motivation in our studies guided by the TDF.

11) To what degree did providers receive an introduction on SBMP prior to the interviews (i.e., the fact that nurse assisted SMBP has been shown to be particularly effective).

Response: All our respondents were trained physicians working in an academic medical center. Most of our respondents used SMBP in some form (in a non-standardized way), with some already using nurse assisted SBPM. Our intent was to elicit existing barriers and facilitators to SBPM use, so we did not offer additional education on SMBP. We have added a line in the first paragraph of the methods section to clarify that we did not offer additional education on SMBP.

12) In the discussion, it was difficult to tease apart whether/how the findings are different from prior research or how their theoretical approach added to prior literature. The utility of using BCW is that you can map to intervention functions/BCTs. Are they any that the authors can glean that should be tested in future research?

Response: We received valuable information based on the BCW. For example,

a) PCPs find it difficult to manage HTN based on in-clinic BP measurements and indicated their support SMBP. However, they need more resources to implement SMBP.

b) PCPs identified that financial incentives alone may not be adequate to implement SMBP.

c) PCPs identified that use of patient portal for SMBP is burdensome and not ideal for many patients

d) PCPs identified potential health care personnel that could assist with SMBP. Although previous studies have indicated that pharmacist can assist with SMBP, PCPs in our study described that additional training may be required to ensure physician confidence. In previous trials where pharmacists have assisted with SMBP, they likely received some additional training. In our interviews, PCPs reiterated the importance of this additional training, which is important for successful implementation.

Consequently, we consider environmental restructuring and enablement to be the most appropriate strategies to address these barriers. We have included these specific terms in the text to tie back to the conceptual model.

13) Do the authors have a sense for which one of the TDF constructs were the most salient (e.g, are underuse mostly driven by opportunity or motivation and less so capability?).

Response: The ‘environmental context and resources’ seemed the most salient. The respondents spent a lot of time discussing the barriers to SMBP that led to less than desired use. We have added this in our discussion.

Reviewer#2

1) This manuscript, entitled “Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study”, is an important contribution to the literature for self-measured blood pressure monitoring.

Response: Thank you.

2) Overall, this is a well-written piece, but it could benefit from some additional copy-editing

Response: Thank you for pointing these out. We have corrected these errors as follows:

a) We have deleted “expected” under “Opportunity” paragraph, third row on page 15 of PDF.

b) We changed “recoding” to “recording” under “Behavioral Regulation” paragraph, third line on page 13 of PDF.

c) We changed “somewhat appropriate” to “somewhat inappropriate” in the second to last column of Table 1 on page 22 of PDF.

d) We changed “HPMB” to “SMPB” in the second column, first entry of Table 2 on page 23 of PDF.

3) Recommend editing your third paragraph in the background to mention home-blood pressure monitoring.

Response: We agree. We have clarified that SMBP is also called home blood pressure monitoring in the introduction section.

4) Could also consider a sentence acknowledging how national initiatives like AMA/AHA’s TargetBP and CDC/CMS’s Million Hearts have been working for years on widespread implementation of SMBP but have not been able to make much headway.

Response: Thank you. We appreciate the suggestion and have added them in the introduction to acknowledge these efforts.

5) For generalizability purposes, this piece could greatly benefit from some additional contextual information about the respondents and their patient populations.

a) For example, the authors provide some written demographic data about respondents (e.g. 15/17 women, 3 geriatricians, mix of both academic and community physicians) but it would be nice to have those data and additional data in a table.

Response: We have added more demographic data of the respondents in the results section. Of the patients with uncontrolled hypertension in the health system, approximately 75% are Caucasian and 18% Black. We expect the respondents to have a similar mix of patients as new patients are randomly assigned physicians in our health system. Obtaining blood pressure control and demographics of specific physicians was outside the scope of our current IRB approval and study design.

b) Would also be nice to understand if any of these 17 key informants were among the physicians who supported SMBP or were they among those who had reservations about using it (from the survey)? Would also be helpful to have some ballpark estimation of what the respondents actual (and perceived if available) BP control rate is for their patient population, what percent of their population has HTN, etc.

Response: We agree. We have added Table 1b presenting survey results for the 14 PCPs who completed the interview. While obtaining the actual BP control rates is outside the scope of this study, table 1 a and b indicate similar physician satisfaction and use of SMBP. We have also added overall BP control in the health system.

c) It would also be helpful to understand a little about the general patient population – e.g. low SES, inner city population; more affluent, mostly-white population. Physician perceptions of barriers and facilitators are skewed by the patients they serve.

Response: We have added details on the general patient population in the subsection “setting” under methods. Evaluating socioeconomic status was beyond the scope of this project as the health system does not enter this information into the EHR. The respondents are expected to have a similar mix of patients as the rest of the health system as in our health system, most new patients are randomly assigned to available physicians.

6) You mention CPC+. Consider talking more generally about pay-for-quality initiatives because CPC+ is just one of many initiatives in that space.

Response: We agree. We have changed the sentence to “A few physicians were aware of the health systems participation in pay for quality initiatives such as Comprehensive Primary Care Plus (CPC+), a CMS program, that provides financial incentives for improving primary care delivery, and felt motivated to use SMBP.” to indicate that CPC+ is one of the quality initiatives and our physicians were motivated to use SMBP as our institution participates in CPC+. We specifically mentioned CPC+ as we have it in our health system and the respondents discussed it in their interviews.

7) You parenthetically mention “A Million Hearts Initiative”. Would recommend changing that to “Million Hearts” and adding more context or a citation there as well. Million Hearts is a major supporter of SMBP but as an initiative, in general, doesn’t pay for monitors.

Response: Thank you for the comment. We have corrected this error and referenced “Million Hearts” (reference number 23) in the introduction section to acknowledge their efforts in SMBP.

8) A potential limitation not noted is the fact that almost all respondents were women. While we don’t necessarily have any reason to believe women would have different perceptions about SMBP than men, it is fairly unusual for 88% of respondents in any study to be women and should at least be noted.

Response: We have added this limitation. Interestingly, most of the attendees of the faculty meetings where the initial survey was introduced were women leading to this sex discrepancy.

9) Another potential limitation is, depending on your response to one of my questions above, the respondents were likely all supporters of SMBP so their barriers are already skewed towards people who trust SMBP. Responses would have differed if respondents included physicians who don’t use SMBP with their patients or who don’t trust the readings, etc.

Response: We have added Table 1b presenting the survey responses from the 14 PCPs who participated in the initial survey and the interviews. Their responses are similar to the responses in Table 1a (from 39 PCPs).

10) I would caution you in the future to separate the use of blood pressure kiosks (i.e. found in pharmacies/grocery stores) from SMBP performed on a patient’s own blood pressure monitor. Not a lot of evidence behind the former, lots behind the latter. If you discussed both of them equivalently with physicians in your interviews (the way it was denoted in the survey), that may have skewed their perceptions. May want to list this as a potential limitation.

Response: We agree. We were trying to limit the number of questions in the initial survey and thus ended up combining these as out of office BP in one of the questions. For the interviews we used the term ‘home BP monitoring’ (that did not include use of blood pressure kiosks) (supplementary data 1).

11) Future research is not noted but there seemed to be some gaps in in what was asked of these physicians. For example, what were their feelings about blood pressure device loaner programs (where health care settings bulk purchase devices and loan them out to patients on a temporary basis)? Were they aware of the new CPT codes that were introduced in 2020 that would reimburse clinicians one time to train patients on SMBP technique/perform device calibration (99473) and reimburse physicians up to monthly to receive SMBP readings, interpret, and combine into a patient’s care plan (99474)?

Response: We agree that these would add to the information collected. Since we started the interviews in late 2019 - early 2020, we did not ask about the new CPT codes. None of the respondents mentioned them either. Our institution does not have a BP loaner program and thus we did not ask about that either. We have added these to our limitations.

12) References 30 and 46 appear to be the same reference.

Response: Thank you for pointing this out. We have corrected the references.

Other changes:

Minor changes in the abstract

We found some errors in Table and have corrected them.

Additional changes in discussion to decrease the overall word count

We replaced Figure 1 due to a typo in the original figure

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Vijayaprakash Suppiah

21 Jun 2021

PONE-D-20-38491R1

Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study

PLOS ONE

Dear Dr. Gupta,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

Please incorporate the second reviewer's minor comments. 

Thank you.

regards,

Vijay. 

===============================

Please submit your revised manuscript by Aug 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Vijayaprakash Suppiah, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: This manuscript, entitled “Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study”, is an important contribution to the literature for self-measured blood pressure monitoring. The authors have done a nice job addressing previous reviewer comments.

A few minor comments:

1. Suggest reviewing it again for grammar editing – found multiple punctuation (e.g. inconsistent use of Oxford comma), spelling (e.g. “specifc”, “fulfil”), and grammar mistakes (e.g. missing hyphens in compound adjectives like “patient care related”, “evidence based”). Proper grammar and editing will add needed clarity throughout.

2. Suggest editing the sentence “A majority of patients are Caucasian, 6% Hispanic, 2.5% Asian, 1.7% Black, and 18% unknown or other.” to “The racial/ethnic breakdown of patients was XX% Caucasian, 6% Hispanic, 2.5% Asian, 1.7% Black, and 18% unknown or other.

3. “Approximately 49% of all patients with a BP reading had atleast…” – need a space in ‘at least’.

4. You use both “White” and “Caucasian” in describing race in your study. Suggest picking one (White).

5. Under the Opportunity section, the authors state “Physicians saw an opportunity for SMBP. Under Social Influences, most physicians identified published evidence as the major reason for using SMBP, and not peer influence. Since SMBP is backed by evidence, some PCPs found it concerning if others did not use SMBP. Only a change in evidence, and not the behavior of their colleagues, would make them not use SMBP (Table 3, social influences).” The finding that is more interesting than what would make SMBP users change their practice is what would make SMBP non-users change their practice. The way this paragraph is written, there is no opportunity on which we can act.

6. “Under Behavioral Regulation respondents elaborated differences in using SMBP for managing HTN.” Need the word “on” after “elaborated”.

7. “Despite their beliefs in the strong evidence behind SMBP, there was underutilization of SMBP due to logistical barriers, lack of resources and trained personnel to help with SMBP.” – need an “and” before “lack”

8. “…suggesting need for better strategies to monitor SMBP” – need the word “the” before “need”

9. “(such as use of patient portal for entering SMBP)” – need “the” or “a” before “patient portal”

10. “performance assessments, standardized protocols” – need an “and” after the comma

11. “With stakeholders; patients, physicians, health systems and insurers interested in adopting SMBP, practical strategies that are scalable are needed.” – this is an awkward sentence. Suggest rewrite of “With stakeholders such as patients, physicians, health systems, and insurers interested in adopting SMBP, practical, scalable strategies are needed.”

12. Table 2 says SMPB instead of SMBP

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Nathalie Moise

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-20-38491 reviewer comments 6-16-21.docx

PLoS One. 2021 Aug 20;16(8):e0255578. doi: 10.1371/journal.pone.0255578.r004

Author response to Decision Letter 1


15 Jul 2021

We thank the editors and the reviewers for their thoughtful feedback. Our responses to the concerns are outlined below.

Reviewer #2

1) This manuscript, entitled “Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study”, is an important contribution to the literature for self-measured blood pressure monitoring. The authors have done a nice job addressing previous reviewer comments.

Response: Thank you.

2) Suggest reviewing it again for grammar editing.

Response: Thank you for pointing out errors, typos and unclear sentences. We have reviewed the entire manuscript again and corrected these errors according to your suggestions.

3) Under the Opportunity section, the authors state “Physicians saw an opportunity for SMBP. Under Social Influences, most physicians identified published evidence as the major reason for using SMBP, and not peer influence. Since SMBP is backed by evidence, some PCPs found it concerning if others did not use SMBP. Only a change in evidence, and not the behavior of their colleagues, would make them not use SMBP (Table 3, social influences).” The finding that is more interesting than what would make SMBP users change their practice is what would make SMBP non-users change their practice. The way this paragraph is written, there is no opportunity on which we can act.

Response: We agree. We have rephrased this section.

Other changes:

We added some more demographic details on primary care providers (requested in the previous review) which we were now able to obtain from our health system.

We removed the abbreviation ‘HTN’ for hypertension.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 2

Vijayaprakash Suppiah

21 Jul 2021

Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study

PONE-D-20-38491R2

Dear Dr. Gupta,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vijayaprakash Suppiah, PhD

Academic Editor

PLOS ONE

Acceptance letter

Vijayaprakash Suppiah

12 Aug 2021

PONE-D-20-38491R2

Physician perceived barriers and facilitators for self-measured blood pressure monitoring- A qualitative study

Dear Dr. Gupta:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vijayaprakash Suppiah

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Identifying barriers and facilitators to home BP monitoring using the theoretical domains framework.

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: PONE-D-20-38491 reviewer comments 6-16-21.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES